Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Published:2021-05 Issue:10289 Volume:397 Page:2070-2080
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rovin Brad H,Teng Y K Onno,Ginzler Ellen M,Arriens Cristina,Caster Dawn J,Romero-Diaz Juanita,Gibson Keisha,Kaplan Joshua,Lisk Laura,Navarra Sandra,Parikh Samir V,Randhawa Simrat,Solomons Neil,Huizinga Robert B

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression;Mahajan;Lupus,2020

2. Update on lupus nephritis: core curriculum 2020;Parikh;Am J Kidney Dis,2020

3. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus;Fanouriakis;Ann Rheum Dis,2019

4. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis;Tamirou;Ann Rheum Dis,2016

5. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort;Dall'Era;Arthritis Rheumatol,2015

Cited by 332 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive drug therapy;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Lupus and infections;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Systemic lupus erythematosus in childhood and adolescence;Dubois' Lupus Erythematosus and Related Syndromes;2025

4. Future directions;Dubois' Lupus Erythematosus and Related Syndromes;2025

5. Management of lupus nephritis;Dubois' Lupus Erythematosus and Related Syndromes;2025